Inhibition of leucocyte elastase by heparin and its derivatives.
Leucocyte proteinases, e.g. leucocyte elastase and cathepsin G, are inhibited by heparin. The activities of pig pancreatic and Pseudomonas aeruginosa elastases are unaffected by this polysaccharide. Heparin derivatives of known Mr and degree of sulphation were isolated. The inhibition of leucocyte elastase by these oligosaccharides can be classified as tight-binding hyperbolic non-competitive. Ki values ranged from 40 nM to 100 microM and were found to be inversely correlated with the chain length of the oligosaccharides. Desulphated compounds lacked inhibitory potential towards leucocyte elastase. Over-O-sulphated di- and tetra-saccharides are more potent inhibitors than their over-N-sulphated counterparts. It is proposed that the therapeutic use of heparin and its derivatives could be extended to disease states such as emphysema and rheumatoid arthritis, where the role of leucocyte elastase has been clearly established.
C.N.R.S. U.A. 1174, Université Paris XII, C.H.U. Henri Mondor, Créteil, France.
F
F
Redini
J M
JM
Tixier
M
M
Petitou
J
J
Choay
L
L
Robert
W
W
Hornebeck
D000818:Animals; D006493:Heparin / Q000031:analogs & derivatives* / Q000494:pharmacology*; D007700:Kinetics; D019272:Leukocyte Elastase; D007962:Leukocytes / Q000201:enzymology*; D009842:Oligopeptides / Q000378:metabolism; D009844:Oligosaccharides / Q000494:pharmacology; D010196:Pancreatic Elastase / Q000037:antagonists & inhibitors*; D011480:Protease Inhibitors / Q000494:pharmacology; D051381:Rats; D013329:Structure-Activity Relationship
D009842:Oligopeptides; D009844:Oligosaccharides; D011480:Protease Inhibitors; C015516:succinyl-trialanine-4-nitroanilide; D006493:Heparin; D010196:Pancreatic Elastase; D019272:Leukocyte Elastase